Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matthew F Wszolek, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Hartsough EM, Moran J, Devins K, Wszolek M, Cornejo KM. An Unusual Case of a Scrotal Porocarcinoma and Review of the Literature. Am J Dermatopathol. 2023 Jan 01; 45(1):51-55. PMID: 36484607.
    Citations:    Fields:    
  2. Zhao T, Chuang HW, Cornejo KM, Crotty RK, Dahl DM, Wszolek MF, Zlatev DV, Zietman AL, Wu CL. Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series. Hum Pathol. 2022 10; 128:101-109. PMID: 35926810.
    Citations:    Fields:    Translation:Humans
  3. Ricciardi R, Goldstone RN, Francone T, Wszolek M, Auchincloss H, de Groot A, Shih IF, Li Y. Healthcare Resource Utilization After Surgical Treatment of Cancer: Value of Minimally Invasive Surgery. Surg Endosc. 2022 Oct; 36(10):7549-7560. PMID: 35445834; PMCID: PMC9022614.
    Citations:    Fields:    
  4. Yu A, Yamany T, Mojtahed A, Hanna N, Nicaise E, Harisinghani M, Wu CL, Dahl DM, Wszolek M, Blute ML, Feldman AS. Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification. Urol Oncol. 2022 02; 40(2):59.e1-59.e5. PMID: 34544650.
    Citations:    Fields:    Translation:Humans
  5. Pieretti A, Krasnow R, Drumm M, Gusev A, Dahl DM, McGovern F, Blute ML, Shipley WU, Efstathiou JA, Feldman AS, Wszolek MF. Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy. J Urol. 2021 Jul; 206(1):29-36. PMID: 33617327.
    Citations: 1     Fields:    Translation:Humans
  6. Mokkapati S, Porten SP, Narayan VM, Lim AH, Jayaratna IS, Roth B, Cheng T, Navai N, Wszolek M, Melquist J, Manyam G, Choi W, Broom B, Pretzsch S, Czerniak B, McConkey DJ, Dinney CPN. TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer. Mol Cancer Res. 2020 06; 18(6):811-821. PMID: 32122956.
    Citations:    Fields:    Translation:HumansAnimalsCells
  7. Hanna N, Wszolek MF, Mojtahed A, Nicaise E, Wu B, Gelpi-Hammerschmidt FJ, Salari K, Dahl DM, Blute ML, Harisinghani M, Feldman AS. Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer. J Urol. 2019 11; 202(5):944-951. PMID: 31144593.
    Citations: 5     Fields:    Translation:Humans
  8. Wszolek M. Does knowing the risk of relapse in localized renal cell carcinoma matter? BJU Int. 2019 02; 123(2):201-202. PMID: 30656837.
    Citations:    Fields:    Translation:Humans
  9. Liu Q, Gheorghiu L, Drumm M, Clayman R, Eidelman A, Wszolek MF, Olumi A, Feldman A, Wang M, Marcar L, Citrin DE, Wu CL, Benes CH, Efstathiou JA, Willers H. PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53. Oncogene. 2018 05; 37(21):2793-2805. PMID: 29511347.
    Citations: 20     Fields:    Translation:HumansCells
  10. Sanchez A, Wszolek MF, Niemierko A, Clayman RH, Drumm M, Rodríguez D, Feldman AS, Dahl DM, Heney NM, Shipley WU, Zietman AL, Efstathiou JA. Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer. J Urol. 2018 02; 199(2):407-415. PMID: 28870862.
    Citations: 14     Fields:    Translation:Humans
  11. Roth B, Jayaratna I, Sundi D, Cheng T, Melquist J, Choi W, Porten S, Nitti G, Navai N, Wszolek M, Guo C, Czerniak B, McConkey D, Dinney C. Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. Oncotarget. 2017 May 23; 8(21):34205-34222. PMID: 27494900.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  12. Giacalone NJ, Shipley WU, Clayman RH, Niemierko A, Drumm M, Heney NM, Michaelson MD, Lee RJ, Saylor PJ, Wszolek MF, Feldman AS, Dahl DM, Zietman AL, Efstathiou JA. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. Eur Urol. 2017 06; 71(6):952-960. PMID: 28081860.
    Citations: 76     Fields:    Translation:Humans
  13. Krasnow RE, Drumm M, Roberts HJ, Niemierko A, Wu CL, Wu S, Zhang J, Heney NM, Wszolek MF, Blute ML, Feldman AS, Lee RJ, Zietman AL, Shipley WU, Efstathiou JA. Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy. Eur Urol. 2017 07; 72(1):54-60. PMID: 28040351.
    Citations: 18     Fields:    Translation:Humans
  14. Kenney PA, Nawaf CB, Mustafa M, Wen S, Wszolek MF, Pettaway CA, Ward JF, Davis JW, Pisters LL. Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy. Can J Urol. 2016 Jun; 23(3):8271-7. PMID: 27347619.
    Citations: 10     Fields:    Translation:Humans
  15. Sanchez A, Wszolek MF. Bladder cancer: Quality of life in patients with non-muscle-invasive bladder cancer. Nat Rev Urol. 2015 Apr; 12(4):186-8. PMID: 25644153.
    Citations: 5     Fields:    Translation:Humans
  16. Wszolek MF, Canes D, Moinzadeh A, Sorcini A. Laparoscopy for the detection and treatment of early complications from minimally invasive urologic surgery. J Endourol. 2014 Oct; 28(10):1197-201. PMID: 22734847.
    Citations:    Fields:    Translation:Humans
  17. Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S, Cai J, Groshen S, Siefker-Radtke A, Millikan RE, Czerniak B, Navai N, Wszolek MF, Kamat AM, Dinney CP. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol. 2014 Jan; 191(1):40-7. PMID: 23911605; PMCID: PMC4158919.
    Citations: 60     Fields:    Translation:Humans
  18. Dinney CP, Fisher MB, Navai N, O'Donnell MA, Cutler D, Abraham A, Young S, Hutchins B, Caceres M, Kishnani N, Sode G, Cullen C, Zhang G, Grossman HB, Kamat AM, Gonzales M, Kincaid M, Ainslie N, Maneval DC, Wszolek MF, Benedict WF. Phase I trial of intravesical recombinant adenovirus mediated interferon-a2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer. J Urol. 2013 Sep; 190(3):850-6. PMID: 23507396; PMCID: PMC3951790.
    Citations: 38     Fields:    Translation:HumansCellsCTClinical Trials
  19. Tran MN, Choi W, Wszolek MF, Navai N, Lee IL, Nitti G, Wen S, Flores ER, Siefker-Radtke A, Czerniak B, Dinney C, Barton M, McConkey DJ. The p63 protein isoform ?Np63a inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J Biol Chem. 2013 Feb 01; 288(5):3275-88. PMID: 23239884.
    Citations: 72     Fields:    Translation:HumansCells
  20. Adam L, Wszolek MF, Liu CG, Jing W, Diao L, Zien A, Zhang JD, Jackson D, Dinney CP. Plasma microRNA profiles for bladder cancer detection. Urol Oncol. 2013 Nov; 31(8):1701-8. PMID: 22863868.
    Citations: 40     Fields:    Translation:HumansCells
  21. Wszolek MF, Kenney PA, Libertino JA. Nonclamping partial nephrectomy: towards improved nephron sparing. Nat Rev Urol. 2011 Aug 02; 8(9):523-7. PMID: 21811227.
    Citations: 3     Fields:    Translation:HumansAnimals
  22. Wszolek MF, Kenney PA, Lee Y, Libertino JA. Comparison of hilar clamping and non-hilar clamping partial nephrectomy for tumours involving a solitary kidney. BJU Int. 2011 Jun; 107(12):1886-92. PMID: 21070570.
    Citations: 10     Fields:    Translation:Humans
  23. Kenney PA, Wszolek MF, Rieger-Christ KM, Neto BS, Gould JJ, Harty NJ, Mosquera JM, Zeheb R, Loda M, Darling DS, Libertino JA, Summerhayes IC. Novel ZEB1 expression in bladder tumorigenesis. BJU Int. 2011 Feb; 107(4):656-63. PMID: 20735391.
    Citations: 35     Fields:    Translation:HumansCells
  24. Gould JJ, Kenney PA, Rieger-Christ KM, Silva Neto B, Wszolek MF, LaVoie A, Holway AH, Spurrier B, Austin J, Cammarata BK, Canes D, Libertino JA, Summerhayes IC. Identification of tumor and invasion suppressor gene modulators in bladder cancer by different classes of histone deacetylase inhibitors using reverse phase protein arrays. J Urol. 2010 Jun; 183(6):2395-402. PMID: 20403623.
    Citations: 7     Fields:    Translation:HumansCells
  25. Wszolek MF, Rieger-Christ KM, Kenney PA, Gould JJ, Silva Neto B, Lavoie AK, Logvinenko T, Libertino JA, Summerhayes IC. A MicroRNA expression profile defining the invasive bladder tumor phenotype. Urol Oncol. 2011 Nov-Dec; 29(6):794-801.e1. PMID: 19945312.
    Citations: 64     Fields:    Translation:Humans
  26. Fernández CA, Wszolek MF, Loughlin KR, Libertino JA, Summerhayes IC, Shuber AP. A novel approach to using matrix metalloproteinases for bladder cancer. J Urol. 2009 Nov; 182(5):2188-94. PMID: 19758628.
    Citations: 10     Fields:    Translation:Humans
  27. Kenney PA, Wszolek MF, Gould JJ, Libertino JA, Moinzadeh A. Face, content, and construct validity of dV-trainer, a novel virtual reality simulator for robotic surgery. Urology. 2009 Jun; 73(6):1288-92. PMID: 19362352.
    Citations: 51     Fields:    Translation:Humans
  28. Wotkowicz C, Wszolek MF, Libertino JA. Resection of renal tumors invading the vena cava. Urol Clin North Am. 2008 Nov; 35(4):657-71; viii. PMID: 18992619.
    Citations: 12     Fields:    Translation:Humans
  29. Fernandez CA, Wszolek MF, Duchesne AR, Feng Y, Patel S, Robison L, Libertino JA, Summerhayes IC, Shuber AP. Development of a novel intervention diagnostic assay for managing bladder cancer survivors using urinary biomarkers. J Clin Oncol. 2008 May 20; 26(15_suppl):22097. PMID: 27950581.
    Citations:    
  30. Wszolek MF, Wotkowicz C, Libertino JA. Surgical management of large renal tumors. Nat Clin Pract Urol. 2008 Jan; 5(1):35-46. PMID: 18185512.
    Citations: 6     Fields:    Translation:Humans
  31. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science. 2001 Jul 27; 293(5530):711-4. PMID: 11408621.
    Citations: 368     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Wszolek's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (184)
Explore
_
Co-Authors (30)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.